MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

Conditions:   Melanoma;   Melanoma, Uveal;   Head and Neck Cancer Intervention:   Biological: Adoptive therapy with autologous MC2 TCR T cells Sponsors:   Erasmus Medical Center;   Ludwig Institute for Cancer Research;   Dutch Cancer Society;   Stichting Coolsingel Rotterdam grant;   Jan Ivo Stichting grant Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials